122 related articles for article (PubMed ID: 10094235)
21. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
22. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
23. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
24. Indices of brain beta-adrenergic receptor signal transduction in the learned helplessness animal model of depression.
Gurguis GN; Kramer G; Petty F
J Psychiatr Res; 1996; 30(2):135-46. PubMed ID: 8816307
[TBL] [Abstract][Full Text] [Related]
25. Presynaptic serotonin mechanisms in rats subjected to inescapable shock.
Edwards E; Kornrich W; Houtten PV; Henn FA
Neuropharmacology; 1992 Apr; 31(4):323-30. PubMed ID: 1387924
[TBL] [Abstract][Full Text] [Related]
26. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat.
Burnet PW; Michelson D; Smith MA; Gold PW; Sternberg EM
Brain Res; 1994 Feb; 638(1-2):311-24. PubMed ID: 8199869
[TBL] [Abstract][Full Text] [Related]
27. Animal models for studying serotonin (5-HT) receptor subtypes: relationship to 5-HT system pathologies.
Ogren SO; Misane I
Nucl Med Biol; 1998 Nov; 25(8):747-9. PubMed ID: 9863561
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptors and learned helplessness in the rat: an autoradiographic study.
Kram ML; Kramer GL; Ronan PJ; Steciuk M; Petty F
Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):639-45. PubMed ID: 12188094
[TBL] [Abstract][Full Text] [Related]
29. Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain.
Wedzony K; Maćkowiak M; Czyrak A; Fijał K; Michalska B
Brain Res; 1997 May; 756(1-2):84-91. PubMed ID: 9187317
[TBL] [Abstract][Full Text] [Related]
30. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
31. Effects of 8-OHDPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats.
Romaniuk A; Koprowska M; Krotewicz M; Strzelczuk M; Wieczorek M
Behav Brain Res; 2001 Apr; 120(1):47-57. PubMed ID: 11173084
[TBL] [Abstract][Full Text] [Related]
32. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex.
Casanovas JM; Hervás I; Artigas F
Neuroreport; 1999 May; 10(7):1441-5. PubMed ID: 10380960
[TBL] [Abstract][Full Text] [Related]
33. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
34. Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats.
Ciccocioppo R; Angeletti S; Colombo G; Gessa G; Massi M
Eur J Pharmacol; 1999 May; 373(1):13-9. PubMed ID: 10408247
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
36. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
37. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
38. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
[TBL] [Abstract][Full Text] [Related]
39. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
Martin P
Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
[TBL] [Abstract][Full Text] [Related]
40. The influence of gender and age on neonatal rat hypothalamic 5-HT1A and 5-HT2A receptors.
Ferrari PF; Lowther S; Tidbury H; Greengrass P; Wilson CA; Horton RW
Cell Mol Neurobiol; 1999 Dec; 19(6):775-84. PubMed ID: 10456237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
